Tag: for-multiple

Moffitt Cancer Center Research Aims to Reduce Health Care Disparities

| March 26, 2015 | 0 Comments

The lesbian, gay, bisexual, transgender/transsexual, queer/questioning and intersex (LGBTQI) population has been largely understudied by the medical community.

Continue Reading

Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to Jointly Develop and Commercialize Anti-PD-L1 to …

| November 17, 2014 | 0 Comments

Pfizer Inc. announced today that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, to jointly develop and commercialize MSB0010718C, an investigational anti-PD-L1 antibody currently in development by Merck KGaA as a potential treatment for multiple types of cancer.

Continue Reading

CANCER HOPEMassive measles vaccine blast kills woman's cancer

| May 15, 2014 | 0 Comments

Can measles or polio be next cure for cancer?

Continue Reading

What is multiple myeloma cancer? – Boston.com

| February 14, 2014 | 0 Comments

Tom Brokaw, a special correspondent for NBC News, is being treated for multiple myeloma. An oncologist at Dana Farber in Boston, who is not treating Brokaw, shared the latest prognosis on treating and surviving this type of cancer.

Continue Reading

What is multiple myeloma cancer?

| February 14, 2014 | 0 Comments

NBC News announced Tuesday that Tom Brokaw, a special correspondent for the news station, is being treated for multiple myeloma, a type of bone marrow cancer that he was diagnosed with in August at the Mayo Clinic.

Continue Reading

Cancer drugs proving worth earlier in testing

| February 25, 2013 | 0 Comments

It typically has taken a decade and $1 billion to bring a new treatment to market. But in the last two years a handful of cancer drugs – including Onyx Pharmaceutical Inc's Kyprolis for multiple myeloma, Roche's Zelboraf for melanoma, and Pfizer's Xalkori – were approved in about half that time because of improved genetic screening, more definitive Phase I trials and the dire need for new …

Continue Reading